Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
MEET THE TEAM
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
How investors can manage political risk in the UK market
Most investors have long recognised the role UK government policy, regulatory change and stakeholder scrutiny can have on their investments. But with electoral politics now changing as rapidly as financial and operational environments, politics is increasingly shaping deal outcomes and portfolio value.
Energy Secretary Ed Miliband Faces Committee – Industry Insights
Brevia Energy dissects the key insights from the Energy Security and Net Zero Select Committee session with Energy Secretary Ed Miliband.
Government Confirms Final CfD Reforms Ahead of Allocation Round 7: Key Takeaways
The UK Government has published its final set of reforms to the Contracts for Difference (CfD) scheme ahead of Allocation Round 7 (AR7), introducing key changes aimed at strengthening investment certainty, increasing delivery flexibility, and securing better value for consumers. In this article, Brevia reviews the reforms and considers what they mean for businesses.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.
